Inci Kamil, Aygencel Gulbin, Dundar Nazlihan Boyaci, Helvaci Ozant, Turkoglu Melda
Division of Critical Care, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkiye.
Division of Nephrology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkiye.
North Clin Istanb. 2024 Sep 27;11(5):414-421. doi: 10.14744/nci.2024.30040. eCollection 2024.
Sepsis-induced acute kidney injury (AKI) is a significant threat, contributing to worse outcomes in intensive care unit (ICU) patients. Thus, understanding the complex relationship between sepsis and renal dysfunction in ICU patients is crucial. We aimed to investigate the factors that may predispose to the development and the clinical consequences of new-onset AKI in septic medical ICU patients in this study.
This retrospective cohort was conducted between December 2019 and April 2023 in the tertiary medical ICU of Gazi University Hospital, Ankara, Turkiye. Participants included septic medical ICU patients aged ≥18 without AKI on ICU admission. Data included demographics, comorbidities, disease severity and prognostic scoring, ICU admission, and ICU follow-up data. Statistical analyses, including logistic regression, were performed to identify independent risk factors for new-onset AKI development and ICU mortality.
Patients with new-onset AKI (36% incidence) had higher APACHE-II (21 [16-27] vs. 16 [12-18]) and SOFA (6 [3-9] vs. 3 [2-5]) scores and lower GCS (10 [6-15] vs. 14 [10-15]) on ICU admission (p<0.01 for all results). Independent risk factors for both new AKI development and ICU mortality included invasive mechanical ventilation (IMV) (OR (95% CI): 5.02 [1.59-15] for AKI and OR (95% CI): 13.2 [3-58.8] for ICU mortality, p<0.01), new-onset shock (OR (95% CI): 3.98 [1.42-11.1] for AKI, OR (95% CI): 14.5 [4.4-43.5] for mortality, p<0.01), and higher APACHE-II score (OR (95% CI): 1.08 [1.01-1.16]), for AKI, p=0.05 and (OR (95% CI): 1.04 [1.01-1.08], for mortality, p=0.01). AKI was more frequent in patients whose source of infection was the respiratory system (45% vs. 29%, p=0.01) and catheter-related bloodstream infection (CRBSI) (17% vs. 8%, p=0.03) than those who did not. New AKI development was associated with longer ICU stay (9 [5-18] vs. 5 [3-10] days, p<0.01) and was independently associated with ICU mortality (OR (95% CI): 28.6 [6.6-125], p<0.01).
This study reveals new-onset AKI incidence of 36% in septic medical ICU patients. Additionally, it underlines the potential impact of infection sources on new AKI development. New-onset shock, IMV, and disease severity were independently associated with both new-onset AKI and ICU mortality in this population.
脓毒症诱发的急性肾损伤(AKI)是一个重大威胁,会导致重症监护病房(ICU)患者出现更差的预后。因此,了解ICU患者脓毒症与肾功能障碍之间的复杂关系至关重要。在本研究中,我们旨在调查可能易患脓毒症医学ICU患者新发AKI的因素及其临床后果。
本回顾性队列研究于2019年12月至2023年4月在土耳其安卡拉加齐大学医院的三级医学ICU进行。参与者包括入住ICU时无AKI的年龄≥18岁的脓毒症医学ICU患者。数据包括人口统计学、合并症、疾病严重程度和预后评分、ICU入院情况以及ICU随访数据。进行了包括逻辑回归在内的统计分析,以确定新发AKI发生和ICU死亡率的独立危险因素。
新发AKI患者(发病率36%)在入住ICU时的急性生理与慢性健康状况评分系统II(APACHE-II)(21[16 - 27]对16[12 - 18])和序贯器官衰竭评估(SOFA)(6[3 - 9]对3[2 - 5])评分更高,格拉斯哥昏迷量表(GCS)评分更低(10[6 - 15]对14[10 - 15])(所有结果p<0.01)。新发AKI和ICU死亡率的独立危险因素包括有创机械通气(IMV)(AKI的比值比(OR)(95%置信区间):5.02[1.59 - 15],ICU死亡率的OR(95%置信区间):13.2[3 - 58.8],p<0.01)、新发休克(AKI的OR(95%置信区间):3.98[1.42 - 11.1],死亡率的OR(95%置信区间):14.5[4.4 - 43.5],p<0.01)以及更高的APACHE-II评分(AKI的OR(95%置信区间):1.08[1.01 - 1.16],p = 0.05;死亡率的OR(95%置信区间):1.04[1.01 - 1.08],p = 0.01)。感染源为呼吸系统的患者(45%对29%,p = 0.01)和导管相关血流感染(CRBSI)的患者(17%对8%,p = 0.03)中AKI比未发生者更常见。新发AKI与更长的ICU住院时间相关(9[5 - 18]天对(5[3 - 10])天,p<0.01),并且与ICU死亡率独立相关(OR(95%置信区间):28.6[6.6 - 125],p<0.01)。
本研究揭示了脓毒症医学ICU患者新发AKI的发病率为36%。此外,它强调了感染源对新发AKI发生的潜在影响。在该人群中,新发休克、IMV和疾病严重程度与新发AKI和ICU死亡率均独立相关。